Willingness to pay and quality of life in patients with rosacea

Beikert, Florian C.; Langenbruch, Anna; Radtke, Marc Alexander; Augustin, Matthias

doi:10.1111/j.1468-3083.2012.04549.x

Cited by 48 publications

(61 citation statements)

References 28 publications

(60 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…To reduce the potential bias of income levels on WTP [14], patients were additionally asked about the percentage of their monthly income they were willing to invest for a complete cure while the payment is conducted. Here, only 14.6% of the participants were willing to spend more than 10% of their monthly income, compared to 58.6% of patients with atopic dermatitis [14] and 37.7% of patients with rosacea [15]. Therefore, the results indicate that insect venom allergy is associated with a moderate disease burden.…”

Section: Discussionmentioning

confidence: 85%

“…Using the WTP method, we could show that with a WTP of EUR 1,727 (median: 500) as one-time payment for a complete cure of the allergy, the disease burden of patients with insect venom allergy was comparable with the burden of patients with rosacea (mean WTP: EUR 2,880, median: 500) [15], while patients suffering from vitiligo (mean: EUR 7,360, median: 3,000) [17] and atopic dermatitis (mean: EUR 11,884, median 1,000) [14] are willing to pay higher amounts for a complete healing. To reduce the potential bias of income levels on WTP [14], patients were additionally asked about the percentage of their monthly income they were willing to invest for a complete cure while the payment is conducted.…”

Section: Discussionmentioning

confidence: 99%

“…No published literature on WTP in patients with venom allergy has been found. WTP had been measured in various dermatological disorders, e.g., psoriasis vulgaris [12, 13], atopic dermatitis [12, 14], rosacea [15], port wine stains [16], and vitiligo [15, 17], which, in contrast to insect venom allergy, have all ongoing clinical symptoms.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Disease Burden, Psychological Well-Being and Attitudes regarding the Set of Emergency Medication in Adults with Insect Venom Allergy

Schaarschmidt

Gutknecht

Schoeben

et al. 2018

Int Arch Allergy Immunol

View full text Add to dashboard Cite

Background: Insect venom allergy is common and greatly impairs patients’ quality of life. Additionally, low compliance with carrying emergency medication is reported. The aim of our study was to analyze the disease burden, levels of anxiety and depression, and to evaluate attitudes towards the set of emergency medication in affected patients. Methods: Between April 2016 and January 2017, patients ≥18 years visiting our department because of an insect venom allergy were asked to complete a paper-based questionnaire. The questionnaire assessed willingness to pay (WTP), the Hospital Anxiety and Depression Scale (HADS), subjective anxiety levels, willingness to carry the set of emergency medication, self-assurance in using it, compliance with carrying it, and reasons for not always carrying it. Results: 55 patients (81.8% wasp allergy) were included. On average, WTP for a complete cure was EUR 1,727 (median: 500). Using the HADS, 14.5% showed definite anxiety disorders while 5.5% had significant depression disorders. Most patients stated to carry the emergency medication “always” (25.5%) or “almost always” (47.3%). “Forgetfulness” (36.4%) was reported as the main reason for not always carrying the medication, followed by “too big” (18.2%). Conclusions: In our patient cohort, insect venom allergy was associated with a moderate disease burden and a good compliance with carrying the emergency medication. However, several of our participants demonstrated borderline or significant anxiety and/or depression disorders. In this regard, this study highlights the necessity to regularly ask the patient about the psychological well-being to identify patients needing psychological support.

show abstract

Section: Discussionmentioning

confidence: 85%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Disease Burden, Psychological Well-Being and Attitudes regarding the Set of Emergency Medication in Adults with Insect Venom Allergy

Schaarschmidt

Gutknecht

Schoeben

et al. 2018

Int Arch Allergy Immunol

View full text Add to dashboard Cite

show abstract

“…Examples of the single-disease literature are shown in the full report. 5,[18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37]…”

Section: Other Indirect Costs Attributable To Skin Diseasementioning

confidence: 99%

The burden of skin disease in the United States

Lim

Collins²,

Resneck

et al. 2017

Journal of the American Academy of Dermatology

363

309

View full text Add to dashboard Cite

Since the publication of the last US national burden of skin disease report in 2006, there have been substantial changes in the practice of dermatology and the US health care system. These include the development of new treatment modalities, marked increases in the cost of medications, increasingly complex payer rules and regulations, and an aging of the US population. Recognizing the need for up-to-date data to inform researchers, policy makers, public stakeholders, and health care providers about the impact of skin disease on patients and US society, the American Academy of Dermatology produced a new national burden of skin disease report. Using 2013 claims data from private and governmental insurance providers, this report analyzed the prevalence, cost, and mortality attributable to 24 skin disease categories in the US population. In this first of 3 articles, the presented data demonstrate that nearly 85 million Americans were seen by a physician for at least 1 skin disease in 2013. This led to an estimated direct health care cost of $75 billion and an indirect lost opportunity cost of $11 billion. Further, mortality was noted in half of the 24 skin disease categories.

show abstract

“…Rosacea can interfere with patients' social, career and everyday life activities, and may involve financial burden and decreased health-related quality of life (3)(4)(5). There is a great demand among rosacea patients for more information about various aspects of the disease (6).…”

Section: Introductionmentioning

confidence: 99%

Rosacea patients seeking advice: Qualitative analysis of patients’ posts on a rosacea support forum

Alinia

Tuchayi

Farhangian

et al. 2016

Journal of Dermatological Treatment

View full text Add to dashboard Cite

Willingness to pay and quality of life in patients with rosacea

Abstract: Rosacea patients show a moderate WTP and average QoL reduction is mild. WTP proved to be a valid tool to assess patients' burden of disease. Patient education and the development of effective treatment options might still improve patients' satisfaction.

Cited by 48 publications

References 28 publications

Disease Burden, Psychological Well-Being and Attitudes regarding the Set of Emergency Medication in Adults with Insect Venom Allergy

Disease Burden, Psychological Well-Being and Attitudes regarding the Set of Emergency Medication in Adults with Insect Venom Allergy

The burden of skin disease in the United States

Rosacea patients seeking advice: Qualitative analysis of patients’ posts on a rosacea support forum

Contact Info

Product

Resources

About